Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Two families with TET3-related disorder showing neurodevelopmental delay with craniofacial dysmorphisms

Journal of Human Genetics volume 67, pages 157–164 (2022)Cite this article

Subjects

Abstract

TET3 at 2p13.1 encodes tet methylcytosine dioxygenase 3, a demethylation enzyme that converts 5-methylcytosine to 5-hydroxymethylcytosine. Beck et al. reported that patients with TET3 abnormalities in either an autosomal dominant or recessive inheritance fashion clinically showed global developmental delay, intellectual disability, and dysmorphisms. In this study, exome sequencing identified both mono- and biallelic TET3 variants in two families: a de novo variant NM_001287491.1:c.3028 A > G:p.(Asn1010Asp), and compound heterozygous variants NM_001287491.1:c.[2077 C > T];[2896 T > G],p.[Gln693*];[Cys966Gly]. Despite the different inheritance modes, the affected individuals showed similar phenotypic features. Including these three patients, only 14 affected individuals have been reported to date. The accumulation of data regarding individuals with TET3-related disorder is necessary to describe their clinical spectrum.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Clinical features of three patients with TET3-related disorder.
Fig. 2: Pathogenic variants causing TET3-related disorder.
Fig. 3: Crystal structure of TET2 (PDB:5DEU) [19] bound to DNA.

Similar content being viewed by others

References

  1. Wu X, Zhang Y. TET-mediated active DNA demethylation: mechanism, function and beyond. Nat Rev Genet. 2017;18:517–34.

    Article  CAS  Google Scholar 

  2. Leturcq M, Lefebvre T, Vercoutter-Edouart AS. O-GlcNAcylation and chromatin remodeling in mammals: An up-to-date overview. Biochem Soc Trans. 2017;45:323–38.

    Article  CAS  Google Scholar 

  3. Konzman D, Abramowitz LK, Steenackers A, Mukherjee MM, Na HJ, Hanover JA. O-GlcNAc: regulator of signaling and epigenetics linked to X-linked intellectual disability. Front Genet. 2020;11:1–19.

    Article  Google Scholar 

  4. Kizuka Y, Kitazume S, Okahara K, Villagra A, Sotomayor EM, Taniguchi N. Epigenetic regulation of a brain-specific glycosyltransferase N-acetylglucosaminyltransferase-IX (GnT-IX) by specific chromatin modifiers. J Biol Chem. 2014;289:11253–61.

    Article  CAS  Google Scholar 

  5. Deplus R, Delatte B, Schwinn MK, Defrance M, Méndez J, Murphy N, et al. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J. 2013;32:645–55.

    Article  CAS  Google Scholar 

  6. Shilatifard A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu Rev Biochem. 2012;81:65–95.

    Article  CAS  Google Scholar 

  7. Szwagierczak A, Bultmann S, Schmidt CS, Spada F, Leonhardt H. Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res 2010; 38. https://doi.org/10.1093/nar/gkq684.

  8. Santiago M, Antunes C, Guedes M, Iacovino M, Kyba M, Reik W, et al. Tet3 regulates cellular identity and DNA methylation in neural progenitor cells. Cell Mol Life Sci. 2019;77:2871–83.

    Article  Google Scholar 

  9. Gu TP, Guo F, Yang H, Wu HP, Xu GF, Liu W, et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature. 2011;477:606–12.

    Article  CAS  Google Scholar 

  10. Inoue A, Shen L, Matoba S, Zhang Y. Haploinsufficiency, but not defective paternal 5mC oxidation, accounts for the developmental defects of maternal Tet3 knockouts. Cell Rep. 2015;10:463–70.

    Article  CAS  Google Scholar 

  11. Tsukada YI, Akiyama T, Nakayama KI. Maternal TET3 is dispensable for embryonic development but is required for neonatal growth. Sci Rep. 2015;5:1–13.

    Article  Google Scholar 

  12. Beck DB, Petracovici A, He C, Moore HW, Louie RJ, Ansar M, et al. Delineation of a human mendelian disorder of the DNA demethylation machinery: TET3 deficiency. Am J Hum Genet. 2020;106:234–45.

    Article  CAS  Google Scholar 

  13. Uchiyama Y, Yamaguchi D, Iwama K, Miyatake S, Hamanaka K, Tsuchida N, et al. Efficient detection of copy-number variations using exome data: Batch- and sex-based analyses. Hum Mutat. 2021;42:50–65.

    Article  CAS  Google Scholar 

  14. Sakamoto M, Iwama K, Sekiguchi F, Mashimo H, Kumada S, Ishigaki K, et al. Novel EXOSC9 variants cause pontocerebellar hypoplasia type 1D with spinal motor neuronopathy and cerebellar atrophy. J Hum Genet. 2021;66:401–7.

    Article  CAS  Google Scholar 

  15. Higasa K, Miyake N, Yoshimura J, Okamura K, Niihori T, Saitsu H, et al. Human genetic variation database, a reference database of genetic variations in the Japanese population. J Hum Genet. 2016;61:547–53.

    Article  CAS  Google Scholar 

  16. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.

    Article  Google Scholar 

  17. Guerois R, Nielsen JE, Serrano L. Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J Mol Biol. 2002;320:369–87.

    Article  CAS  Google Scholar 

  18. Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L. The FoldX web server: an online force field. Nucleic Acids Res. 2005;33:382–8.

    Article  Google Scholar 

  19. Hu L, Lu J, Cheng J, Rao Q, Li Z, Hou H, et al. Structural insight into substrate preference for TET-mediated oxidation. Nature. 2015;527:118–22.

    Article  CAS  Google Scholar 

  20. Hu L, Li Z, Cheng J, Rao Q, Gong W, Liu M, et al. Crystal Structure of TET2-DNA Complex: Insight into TET-Mediated 5mC Oxidation. Cell. 2013;155:1545–55.

    Article  CAS  Google Scholar 

  21. Maquat LE. Nonsense-mediated mRNA decay: Splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol. 2004;5:89–99.

    Article  CAS  Google Scholar 

  22. Xu Y, Xu C, Kato A, Tempel W, Abreu JG, Bian C, et al. Tet3 CXXC domain and dioxygenase activity cooperatively regulate key genes for xenopus eye and neural development. Cell. 2012;151:1200–13.

    Article  CAS  Google Scholar 

  23. Fang S, Li J, Xiao Y, Lee M, Guo L, Han W, et al. Tet inactivation disrupts YY1 binding and long-range chromatin interactions during embryonic heart development. Nat Commun. 2019;10:1–18.

    Article  Google Scholar 

Download references

Acknowledgements

We thank all patients and their families for their participation in this study. We would like to thank N. Watanabe, T. Miyama, M. Sato, S. Sugimoto, and K. Takabe for their technical assistance. We thank Catherine Perfect, MA (Cantab), from Edanz (https://jp.edanz.com/ac), for editing a draft of this manuscript. R. Seyama, N. Tsuchida, Y. Uchiyama and N. Matsumoto contributed to the study design. R. Seyama, N. Tsuchida, K. Hamada, K. Ogata, Y. Uchiyama and N. Matsumoto performed the data analysis. Y. Okada, S. Sakata, S. Okada and N. Okamoto evaluated clinical information of patients. R. Seyama, Y. Uchiyama and N. Matsumoto prepared the manuscript. N. Matsumoto finalized the manuscript. All authors critically read the manuscript, corrected, and approved the final version of the manuscript.

Funding

This study was supported by the Japan Agency for Medical Research and Development (AMED) (grant numbers: JP21ek0109486, JP21ek0109549, JP21cm0106503, and JP21ek0109493); JSPS KAKENHI (grant numbers: JP20K07907, JP20K08164, JP21k15097, JP20K17428, JP21K07869, and JP20K16932); the Takeda Science Foundation; and the Ichiro Kanehara Foundation for the Promotion of Medical Science and Medical Care.

Author information

Authors and Affiliations

  1. Department of Human Genetics, Yokohama City University, Yokohama, Japan

    Rie Seyama, Naomi Tsuchida, Yoshiteru Azuma, Kohei Hamanaka, Atsushi Fujita, Eriko Koshimizu, Satoko Miyatake, Takeshi Mizuguchi, Yuri Uchiyama & Naomichi Matsumoto

  2. Department of Obstetrics and Gynecology, Juntendo University, Tokyo, Japan

    Rie Seyama & Atsuo Itakura

  3. Department of Rare Disease Genomics, Yokohama City University Hospital, Yokohama, Japan

    Naomi Tsuchida & Yuri Uchiyama

  4. Department of Pediatrics, National Hospital Organization Higashihiroshima Medical Center, Higashihiroshima, Japan

    Yasuyuki Okada

  5. Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan

    Sonoko Sakata & Satoshi Okada

  6. Department of Biochemistry, Yokohama City University, Yokohama, Japan

    Keisuke Hamada & Kazuhiro Ogata

  7. Department of Pediatrics, Aichi Medical University, Nagakute, Japan

    Yoshiteru Azuma

  8. Department of Obstetrics and Gynecology, Juntendo University Urayasu Hospital, Chiba, Japan

    Shintaro Makino

  9. Department of Medical Genetics, Osaka Women’s and Children’s Hospital, Osaka, Japan

    Nobuhiko Okamoto

Authors
  1. Rie Seyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naomi Tsuchida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuyuki Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sonoko Sakata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keisuke Hamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshiteru Azuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kohei Hamanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Atsushi Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Eriko Koshimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Satoko Miyatake
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Takeshi Mizuguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Shintaro Makino
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Atsuo Itakura
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Satoshi Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Nobuhiko Okamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Kazuhiro Ogata
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Yuri Uchiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Naomichi Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naomichi Matsumoto.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seyama, R., Tsuchida, N., Okada, Y. et al. Two families with TET3-related disorder showing neurodevelopmental delay with craniofacial dysmorphisms. J Hum Genet 67, 157–164 (2022). https://doi.org/10.1038/s10038-021-00986-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-021-00986-y

This article is cited by

Search

Advanced search

Quick links